Savara SVRA
NASDAQ SVRA
$4.67 -0.09 (-1.89%)
At close: Oct 21, 2026 · 4:00 PM EDT

Savara (SVRA) Current Leases (2016 - 2018)

Updated

Savara (SVRA) reported Current Leases of $41,000 for Q4 2018, down 84.5% from $265,000 a year earlier and down 87.1% from the prior quarter.

Analysis

Savara (SVRA) Current Leases (2016 - 2018) Analysis & Trends

Dating back to Q4 2016, Savara's Current Leases record includes 8 quarters.

  • By year, Current Leases came in at $265,000 in FY2017 (-40.0%) and $442,000 in FY2016.
  • Five-year quarterly Current Leases spans a low of $21,000 in Q1 2018 and a high of $719,000 in Q2 2017.
  • Year over year, Current Leases gained in 1 of the last four quarters, with an average decline of 40.1%.
  • Per Business Quant data, the three quarters before Q4 2018 came in at $318,000 (Q3 2018), $318,000 (Q2 2018) and $21,000 (Q1 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Savara 1.19 Bn 449.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 41,000.00
Sep 30, 2018 318,000.00
Jun 30, 2018 318,000.00
Mar 31, 2018 21,000.00
Dec 31, 2017 265,000.00
Sep 30, 2017 265,000.00
Jun 30, 2017 719,000.00
Dec 31, 2016 442,000.00
API Access

Savara Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=SVRA&period=max&api_key=YOUR_API_KEY